Analysts Update Their Price Forecasts For GE HealthCare Technologies Inc (GEHC)

GE HealthCare Technologies Inc (GEHC) concluded trading on Wednesday at a closing price of $64.89, with 6.29 million shares of worth about $408.24 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -28.96% during that period and on April 23, 2025 the price saw a gain of about 5.26%. Currently the company’s common shares owned by public are about 456.96M shares, out of which, 456.62M shares are available for trading.

Stock saw a price change of 2.84% in past 5 days and over the past one month there was a price change of -20.58%. Year-to-date (YTD), GEHC shares are showing a performance of -17.00% which decreased to -23.20% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $57.65 but also hit the highest price of $94.80 during that period. The average intraday trading volume for GE HealthCare Technologies Inc shares is 4.04 million. The stock is currently trading -4.78% below its 20-day simple moving average (SMA20), while that difference is down -18.05% for SMA50 and it goes to -22.29% lower than SMA200.

GE HealthCare Technologies Inc (NASDAQ: GEHC) currently have 456.96M outstanding shares and institutions hold larger chunk of about 85.63% of that.

The stock has a current market capitalization of $29.71B and its 3Y-monthly beta is at 1.57. PE ratio of stock for trailing 12 months is 14.94, while it has posted earnings per share of $4.34 in the same period. Its PEG reads 1.64 and has Quick Ratio of 0.79 while making debt-to-equity ratio of 1.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEHC, volatility over the week remained 3.37% while standing at 4.82% over the month.

Stock’s fiscal year EPS is expected to rise by 4.73% while it is estimated to increase by 11.49% in next year. EPS is likely to grow at an annualized rate of 9.13% for next 5-years, compared to annual growth of 5.31% made by the stock over the past 5-years.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on March 11, 2025 offering a Buy rating for the stock and assigned a target price range of between $85 and $100 to it. Coverage by Jefferies stated GE HealthCare Technologies Inc (GEHC) stock as a Buy in their note to investors on January 08, 2025, suggesting a price target of $103 for the stock. On September 26, 2024, UBS Downgrade their recommendations, while on September 18, 2024, BTIG Research Upgrade their ratings for the stock with a price target of $100. Stock get a Neutral rating from JP Morgan on September 09, 2024.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.